Virginie Kerbusch

Pharmacokinetic Properties of Mirabegron, a β3-Adrenoceptor Agonist: Results From Two Phase I, Randomized, Multiple-Dose Studies in Healthy Young and Elderly Men and Women

Walter Krauwinkel, Jan van Dijk, Marloes Schaddelee et al. · Clinical Therapeutics · 2012 · 96 citations

Elderly Men, Pharmacological Study, Pharmacology +8

Single dose pharmacokinetics and absolute bioavailability of mirabegron, a ?3-adrenoceptor agonist for treatment of overactive bladder

Charlotte Eltink, Jennifer Lee, Marloes Schaddelee et al. · International Journal of Clinical Pharmacology and Therapeutics · 2012 · 54 citations

Role of Cytochrome P450 Isoenzymes 3A and 2D6 in the In Vivo Metabolism of Mirabegron, a β3-Adrenoceptor Agonist

Jennifer Lee, Selina Moy, John Meijer et al. · Clinical Drug Investigation · 2013 · 39 citations

Molecular Pharmacology, β3-Adrenoceptor Agonist, Biochemistry +8

Effect of Renal or Hepatic Impairment on the Pharmacokinetics of Mirabegron

James Dickinson, Michaelene Lewand, Taiji Sawamoto et al. · Clinical Drug Investigation · 2012 · 30 citations

Renal Function, Hepatology, Liver Physiology +9

Intestinal Absorption Mechanism of Mirabegron, a Potent and Selective β₃-Adrenoceptor Agonist: Involvement of Human Efflux and/or Influx Transport Systems

Shin Takusagawa, Fumihiko Ushigome, Hiroyuki Nemoto et al. · Molecular Pharmaceutics · 2013 · 25 citations

Expressing Vesicles, Gastrointestinal Pharmacology, Gastroenterology +19